Literature DB >> 21710234

Correlational study of vascular endothelial growth factor expression and microvessel density in primary malignant gastric lymphoma.

Lin Xie1, Li-Da Shen, Chen Qing, Zuo-Zhang Yang, Ke Li, Yang Li, Ji-Lan Yang.   

Abstract

Vascular endothelial growth factor (VEGF) expression and microvessel density (MVD) in primary malignant gastric lymphoma were studied, and their correlation as well as its clinical significance was analyzed. Thirty-five patients diagnosed with primary malignant gastric lymphoma were enrolled in this study. VEGF expression in the tumor tissues was detected by immunohistochemistry. Microvessel density in tumors was counted with Weidner's method and compared with MVD in normal tissues 5 cm away from tumor site. Collected data were analyzed statistically. Our results showed that VEGF expression and MVD in tumor tissues were higher than those in normal tissues, and the difference between these two groups was significant (P < 0.01). As VEGF expression was elevated, MVD was also increased in tumor tissues. Statistical analysis revealed that VEGF expression was positively correlated with MVD (r = 0.392, P < 0.05). VEGF was highly expressed in primary malignant gastric lymphoma and positively correlated with MVD. These results strongly suggest that anti-angiogenesis therapy investigated in gastric lymphoma is a prospective clinical trial.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21710234     DOI: 10.1007/s12032-011-0008-8

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  23 in total

1.  A peptidomimetic antagonist of the integrin alpha(v)beta3 inhibits Leydig cell tumor growth and the development of hypercalcemia of malignancy.

Authors:  C P Carron; D M Meyer; J A Pegg; V W Engleman; M A Nickols; S L Settle; W F Westlin; P G Ruminski; G A Nickols
Journal:  Cancer Res       Date:  1998-05-01       Impact factor: 12.701

2.  [Analysis of prognostic factors in lymph node-negative advanced gastric cancer patients].

Authors:  Chang-qing Zeng; Yu Zheng; Liang-xiang Huang; Jian-dang Li
Journal:  Zhonghua Wei Chang Wai Ke Za Zhi       Date:  2011-02

Review 3.  The biology of vascular endothelial growth factor.

Authors:  N Ferrara; T Davis-Smyth
Journal:  Endocr Rev       Date:  1997-02       Impact factor: 19.871

4.  Occurrence and prognosis of extranodal lymphomas.

Authors:  C Freeman; J W Berg; S J Cutler
Journal:  Cancer       Date:  1972-01       Impact factor: 6.860

Review 5.  Primary gastric lymphoma pathogenesis and treatment: what has changed over the past 10 years?

Authors:  Pier Francesco Ferrucci; Emanuele Zucca
Journal:  Br J Haematol       Date:  2006-12-08       Impact factor: 6.998

Review 6.  Primary gastrointestinal lymphoma.

Authors:  Prasanna Ghimire; Guang-Yao Wu; Ling Zhu
Journal:  World J Gastroenterol       Date:  2011-02-14       Impact factor: 5.742

7.  Rituximab, bevacizumab and CHOP (RA-CHOP) in untreated diffuse large B-cell lymphoma: safety, biomarker and pharmacokinetic analysis.

Authors:  Kristen N Ganjoo; Caroline S An; Michael J Robertson; Leo I Gordon; Joy A Sen; Jill Weisenbach; Shuli Li; Edie A Weller; Attilio Orazi; Sandra J Horning
Journal:  Leuk Lymphoma       Date:  2006-06

8.  Tumour angiogenesis in prostatic carcinoma with and without bone marrow metastasis: a morphometric study.

Authors:  S Wakui; M Furusato; T Itoh; H Sasaki; A Akiyama; I Kinoshita; K Asano; T Tokuda; S Aizawa; S Ushigome
Journal:  J Pathol       Date:  1992-11       Impact factor: 7.996

9.  Comparison of microscopic vascularity in benign and malignant prostate tissue.

Authors:  S A Bigler; R E Deering; M K Brawer
Journal:  Hum Pathol       Date:  1993-02       Impact factor: 3.466

10.  Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer.

Authors:  E R Horak; R Leek; N Klenk; S LeJeune; K Smith; N Stuart; M Greenall; K Stepniewska; A L Harris
Journal:  Lancet       Date:  1992-11-07       Impact factor: 79.321

View more
  2 in total

1.  Immunohistochemistry and scoring of Ki-67 proliferative index and p53 expression in gastric B cell lymphoma from Northern African population: a pilot study.

Authors:  Soumia Zeggai; Noria Harir; Abdelnacer Tou; Feriel Sellam; Meriem N Mrabent; Rachida Salah
Journal:  J Gastrointest Oncol       Date:  2016-06

2.  Clinical Significance of "Double-hit" and "Double-protein" expression in Primary Gastric B-cell Lymphomas.

Authors:  Miaoxia He; Keting Chen; Suhong Li; Shimin Zhang; Jianming Zheng; Xiaoxia Hu; Lei Gao; Jie Chen; Xianmin Song; Weiping Zhang; Jianmin Wang; Jianmin Yang
Journal:  J Cancer       Date:  2016-06-18       Impact factor: 4.207

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.